These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11302413)

  • 21. The antimicrobial resistance profile of Streptococcus pneumoniae.
    Reinert RR
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():7-11. PubMed ID: 19366363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between virulence and resistance to antibiotics in pneumococci. Contribution of experimental data obtained in an animal model].
    Bédos JP; Rolin O; Bouanchaud DH; Pocidalo JJ
    Pathol Biol (Paris); 1991 Dec; 39(10):984-90. PubMed ID: 1805140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).
    Low DE
    Infect Dis Clin North Am; 2013 Mar; 27(1):87-97. PubMed ID: 23398867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?
    Mandell LA; Peterson LR; Wise R; Hooper D; Low DE; Schaad UB; Klugman KP; Courvalin P
    Clin Infect Dis; 2002 Sep; 35(6):721-7. PubMed ID: 12203170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
    Soriano F
    Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibiotic resistance in pneumococci].
    Moreillon P; Wenger A
    Schweiz Med Wochenschr; 1996 Feb; 126(7):255-63. PubMed ID: 8720323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillance.
    Kuster SP; Rudnick W; Shigayeva A; Green K; Baqi M; Gold WL; Lovinsky R; Muller MP; Powis JE; Rau N; Simor AE; Walmsley SL; Low DE; McGeer A;
    Clin Infect Dis; 2014 Oct; 59(7):944-52. PubMed ID: 24973312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for pneumococcal infections: an update.
    Esposito S; Principi N
    Expert Opin Pharmacother; 2013 Jan; 14(1):65-77. PubMed ID: 23256539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.
    Widdowson CA; Klugman KP
    Semin Respir Infect; 1999 Sep; 14(3):255-68. PubMed ID: 10501313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of S. pneumoniae to fluoroquinolines--US, 1995-1999.
    Ann Pharmacother; 2001 Nov; 35(11):1509. PubMed ID: 11724112
    [No Abstract]   [Full Text] [Related]  

  • 31. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-resistant pneumococcal infections in the United States. A problem for clinicians, laboratories, and public health.
    Simberkoff MS
    JAMA; 1994 Jun; 271(23):1875-6. PubMed ID: 8196147
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections.
    Lister PD
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S18-25. PubMed ID: 7729467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigational new drugs for the treatment of resistant pneumococcal infections.
    Hoffman-Roberts HL; C Babcock E; Mitropoulos IF
    Expert Opin Investig Drugs; 2005 Aug; 14(8):973-95. PubMed ID: 16050791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic-resistant pneumococci in pediatric disease.
    Klugman KP; Friedland IR
    Microb Drug Resist; 1995; 1(1):5-8. PubMed ID: 9156379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoroquinolone resistance in Streptococcus pneumoniae.
    Peterson DE; Sahm DF
    N Engl J Med; 1999 Nov; 341(20):1547; author reply 1547-8. PubMed ID: 10577110
    [No Abstract]   [Full Text] [Related]  

  • 37. New prospects for antibacterial agents against multidrug-resistant pneumococci.
    Appelbaum PC
    Microb Drug Resist; 1995; 1(1):43-8. PubMed ID: 9156383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review.
    Siegel M; Timpone J
    Clin Infect Dis; 2001 Mar; 32(6):972-4. PubMed ID: 11247720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients].
    Stephan C; Just-Nübling G; Franck S; Bickel M; Shah PM; Babacan E; Staszewski S
    Med Klin (Munich); 2008 Feb; 103(2):69-74. PubMed ID: 18270662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
    Kelley MA; Weber DJ; Gilligan P; Cohen MS
    Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.